BR0308040A - Composições farmacêuticas e cosméticas compreendendo plgf-1 - Google Patents

Composições farmacêuticas e cosméticas compreendendo plgf-1

Info

Publication number
BR0308040A
BR0308040A BR0308040-4A BR0308040A BR0308040A BR 0308040 A BR0308040 A BR 0308040A BR 0308040 A BR0308040 A BR 0308040A BR 0308040 A BR0308040 A BR 0308040A
Authority
BR
Brazil
Prior art keywords
plgf
cosmetic compositions
pharmaceutical
compositions
scleroderma
Prior art date
Application number
BR0308040-4A
Other languages
English (en)
Inventor
Domenico Maglione
Mauro Battisti
Ettore Conti
Guiseppe Salvia
Marina Tucci
Original Assignee
Geymonat Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11456138&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0308040(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Geymonat Spa filed Critical Geymonat Spa
Publication of BR0308040A publication Critical patent/BR0308040A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"COMPOSIçõES FARMACêUTICAS E COSMéTICAS COMPREENDENDO PLGF-1". A invenção refere-se à preparação de fator de crescimento placentário (PLGF), a qual compreende composições terapêuticas e cosméticas capazes de aumentar a angiogênese do tecido conectivo cutâneo, subcutâneo e de órgãos internos. Tais composições são adequadas para o tratamento de estados patológicos ou naturais que se beneficiam da formação ou regeneração de novos vasos da região cutânea, tal como esclerodermia, suas diversas manifestações, envelhecimento da pele e queda de cabelo.
BR0308040-4A 2002-03-05 2003-03-05 Composições farmacêuticas e cosméticas compreendendo plgf-1 BR0308040A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002RM000119A ITRM20020119A1 (it) 2002-03-05 2002-03-05 Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
PCT/IT2003/000132 WO2003074075A1 (en) 2002-03-05 2003-03-05 Pharmaceutical and cosmetic compositions comprising plgf-1

Publications (1)

Publication Number Publication Date
BR0308040A true BR0308040A (pt) 2004-12-14

Family

ID=11456138

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308040-4A BR0308040A (pt) 2002-03-05 2003-03-05 Composições farmacêuticas e cosméticas compreendendo plgf-1

Country Status (21)

Country Link
US (1) US7364722B2 (pt)
EP (1) EP1482967B1 (pt)
JP (2) JP5010093B2 (pt)
KR (1) KR100988656B1 (pt)
CN (1) CN100467058C (pt)
AU (1) AU2003217464B2 (pt)
BR (1) BR0308040A (pt)
CA (1) CA2477075C (pt)
CY (1) CY1114209T1 (pt)
DK (1) DK1482967T3 (pt)
ES (1) ES2424827T3 (pt)
HK (1) HK1078469A1 (pt)
HR (1) HRP20040914A2 (pt)
IT (1) ITRM20020119A1 (pt)
MX (1) MXPA04008486A (pt)
PL (1) PL371788A1 (pt)
PT (1) PT1482967E (pt)
RU (1) RU2292906C2 (pt)
SI (1) SI1482967T1 (pt)
WO (1) WO2003074075A1 (pt)
ZA (1) ZA200407707B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2872040B1 (fr) * 2004-06-23 2006-09-22 Centre Nat Rech Scient Cnrse Utilisation cosmetique d'au moins un tetrapeptide naturel ac-n-ser-asp-lys-pro- ou un de ses analogues en tant qu'agent antivieillissement et restructurant de la peau
US8057458B2 (en) * 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
CN102307598A (zh) * 2009-02-05 2012-01-04 迪格纳生物技术公司 TGF-β1抑制肽的药物制剂
ES2622155T3 (es) 2009-07-24 2017-07-05 Advanced Accelerator Applications S.A. Compuestos moduladores de la actividad VEGF y usos de los mismos
US10729746B2 (en) 2013-01-28 2020-08-04 Shire Human Genetic Therapies, Inc. Recombinant placenta growth factor for treating Duchenne muscular dystrophy
JP7464348B2 (ja) 2014-01-17 2024-04-09 ミメディクス グループ インコーポレイテッド 血管新生を誘導する方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1242149B (it) 1990-09-27 1994-02-16 Consiglio Nazionale Ricerche Sequenza di nucleotidi codificante per una proteina umana con proprieta' regolative dell'angiogenesi
AU6777196A (en) * 1995-08-15 1997-03-12 Connective Therapeutics Inc. Method of promoting angiogenesis
US7947472B2 (en) * 1997-12-24 2011-05-24 Vegenics Limited Expression vectors and cell lines expressing vascular endothelial growth factor D
WO2001000792A1 (en) * 1999-06-29 2001-01-04 Marchosky J Alexander Compositions and methods for forming and strengthening bone
WO2001057181A2 (en) * 2000-02-04 2001-08-09 Carmeliet, Peter Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
US6773881B2 (en) * 2000-03-31 2004-08-10 The General Hospital Corporation Methods of modulating hair growth

Also Published As

Publication number Publication date
CN1638793A (zh) 2005-07-13
AU2003217464A1 (en) 2003-09-16
CA2477075A1 (en) 2003-09-12
AU2003217464B2 (en) 2007-08-30
CN100467058C (zh) 2009-03-11
ITRM20020119A1 (it) 2003-09-05
PL371788A1 (en) 2005-06-27
HK1078469A1 (en) 2006-03-17
JP5144690B2 (ja) 2013-02-13
RU2004129586A (ru) 2005-06-10
ZA200407707B (en) 2005-07-27
WO2003074075A1 (en) 2003-09-12
US7364722B2 (en) 2008-04-29
ES2424827T3 (es) 2013-10-08
US20050239698A2 (en) 2005-10-27
JP2005519101A (ja) 2005-06-30
MXPA04008486A (es) 2005-04-19
EP1482967B1 (en) 2013-05-15
CA2477075C (en) 2013-08-06
DK1482967T3 (da) 2013-08-26
HRP20040914A2 (en) 2004-12-31
KR20040111379A (ko) 2004-12-31
RU2292906C2 (ru) 2007-02-10
JP5010093B2 (ja) 2012-08-29
PT1482967E (pt) 2013-08-27
ITRM20020119A0 (it) 2002-03-05
EP1482967A1 (en) 2004-12-08
SI1482967T1 (sl) 2013-10-30
KR100988656B1 (ko) 2010-10-18
US20050075288A1 (en) 2005-04-07
CY1114209T1 (el) 2016-08-31
JP2010116405A (ja) 2010-05-27

Similar Documents

Publication Publication Date Title
ES2285859T3 (es) Utilizacion cosmetica o dermofarmaceutica de peptidos para la cicatrizacion, la hidratacion y la mejora del aspecto cutaneo durante el envejecimiento natural o acelerado (heliodermia, contaminacion).
BR0211641A (pt) Compostos anti-envelhecimento e de cura de ferimento
ATE330967T1 (de) An her2 bindende peptidverbindungen
DK0910647T3 (da) Human DNase i hyperaktive varianter
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
AR020055A1 (es) Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma.
ATE446313T1 (de) Muteine von tränen-lipocalin
AP2000001905A0 (en) Peptide compositions and formulations and use of same.
CA2596597A1 (en) Method for stimulation collagen synthesis and/or kgf expression
CY1114209T1 (el) Φαρμακευτικες και καλλυντικες συνθεσεις που περιλαμβανουν plgf-1
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
HUP0101710A2 (hu) Mátrix-protein kompozíciók sebgyógyulás elősegítésére
ATE427956T1 (de) Ckrox-peptide und ihre analoge zur behandlung von hautalterung
CY1109843T1 (el) Αναλογα της βιταμινης d
DE69840497D1 (de) Verwendung von Aplidine zur Behandlung von kardiovaskulären Erkrankungen
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
ATE322878T1 (de) Biotin enthaltende galenische formulierung
BR0315437A (pt) Composição para o tratamento dos cabelos, usos da mesma e método para o tratamento dos cabelos
WO2004076614A3 (de) Humane nukleinsäuresequenzen aus prostatakarzinomen
WO2002015870A3 (de) Substanzen zur induktion und intensivierung der bräuningsmechanismen der haut
AU2003292326A1 (en) Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
MXPA03011622A (es) Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas.
DE69824017D1 (de) Vehikel zur gentherapie enthaltend dermales huellgewebe
ATE555787T1 (de) Behandlungseffekte von überschüssigen reaktiven sauerstoffspezies
WO2003082263A8 (en) Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 38/18 , A61K 7/48 , A61P 17/00 , A61P 17/02 , A61P 17/14

Ipc: A61K 38/18 (2006.01), A61K 8/64 (2006.01), A61P 17

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time